Vergleich

TATA binding protein TBP [1TBP18]

ArtNr 20-272-192108
Hersteller GENWAY
Menge 0.1 mg
Kategorie
Typ Antibody
Applikationen WB, IP
Clon 1TBP18
Specific against other
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-82A8B8
Similar products 20-272-192108
Lieferbar
Genway ID:
GWB-82A8B8
Clone:
1TBP18
Isotype:
IgG1
Immunogen:
Synthetic peptide (Human).
Antigen Species:
HumanEpitope: Within amino acid residues 1-20 of human mouse and rat TBP. The specific epitope for this antibody is accessible when the C-terminal domain of TBP is removed or when TBP is removed or when TBP is complexed with DNA.
Target:
TATA binding protein TBP
Concentration:
Lot specific and is stated on the vial. Storage
Buffer:
PBS with 0. 02% sodium azide
Application Note:
This antibody may be used in Western blot and electrophoretic mobility (gel shift) assays to detect mammalian TBP. It may also be used to immuno-precipitate a truncated TBP molecule containing only the N-terminal domain.
Function:
General transcription factor that functions at the core of the DNA-binding multiprotein factor TFIID. Binding of TFIID to the TATA box is the initial transcriptional step of the pre-initiation complex (PIC) playing a role in the activation of eukaryotic genes transcribed by RNA polymerase II.
Subunit:
Belongs to the TFIID complex together with the TBP-associated factors (TAFs). Component of the transcription factor SL1/TIFIB complex composed of TBP and at least TAF1A TAF1B TAF1C and TAF3. Binds DNA as monomer. Interacts with TAFs TFIIB NCOA6 DRAP1 DR1 and ELF3. Interacts with SPIB SNAPC1 SNAPC2 and SNAPC4. Interacts with HIV-1 Tat. Interacts with UTF1 which acts as a coactivator of ATF2 transcriptional activity. Interacts with GPBP1 (By similarity). Interacts with BRF2.
Subcellular Location:
Nucleus.
Polymorphism:
The poly-Gln region of TBP is highly polymorphic (25 to 42 repeats) in normal individuals and is expanded to about 47-63 repeats in spinocerebellar ataxia 17 (SCA17) patients.
Disease:
Defects in TBP are the cause of spinocerebellar ataxia type 17 (SCA17) [MIM:607136]. Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands speech and eye movements due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA17 is an autosomal dominant cerebellar ataxia (ADCA) characterized by widespread cerebral and cerebellar atrophy dementia and extrapyramidal signs. The molecular defect in SCA17 is the expansion of a CAG repeat in the coding region of TBP. Longer expansions result in earlier onset and more severe clinical manifestations of the disease.
Similarity:
Belongs to the TBP family.

Hinweis: Die dargestellten Informationen und Dokumente (Bedienungsanleitung, Produktdatenblatt, Sicherheitsdatenblatt und Analysezertifikat) entsprechen unserem letzten Update und sollten lediglich der Orientierung dienen. Wir übernehmen keine Garantie für die Aktualität. Für spezifische Anforderungen bitten wir Sie, uns eine Anfrage zu stellen.

Alle Produkte sind nur für Forschungszwecke bestimmt. Nicht für den menschlichen, tierärztlichen oder therapeutischen Gebrauch.

Menge: 0.1 mg
Lieferbar: In stock
lieferbar

Vergleichen

Auf den Wunschzettel

Angebot anfordern

Lieferzeit anfragen

Technische Frage stellen

Bulk-Anfrage stellen

Fragen zum Produkt?
 
Schließen